Bayer (BAYN: DE) has partnered with MOMA Therapeutics to develop a small molecule oncology program using MOMA’s KNOMATIC ...

Pfizer has reportedly ended its Phase II/III trials for sisunatovir, a promising RSV candidate acquired with ReViral in a ...

Cambridge, USA-based City Therapeutics has announced its launch with a vision to lead the future of RNA interference ...

The UK has launched the Regulatory Innovation Office (RIO) to reduce regulatory barriers and fast-track approvals for new ...

Arda Therapeutics, a biotech focused on targeted cell depletion therapies for chronic diseases, has raised $43 million in a ...

US pharma major Bristol Myers Squibb’s recent approval from the US Food and Drug Administration (FDA) for Cobenfy (xanomeline ...

US biotech major Biogen revealed that felzartamab, an investigational anti-CD38 monoclonal antibody, has received ...

German pharma major Bayer has opened Bayer Co.Lab Shanghai, a new life science incubator in China’s Zhangjiang biopharma ...

Purespring Therapeutics, a UK-based gene therapy company focused on kidney disease, has raised £80 million ($105 million) in ...

German family-owned pharma major Boehringer Ingelheim and USA-based Circle Pharma (have entered into a research collaboration and license agreement with the shared goal to develop a first-in-class ...

Sage Therapeutics’ share price fell 11% to $6 in pre-market activity on Tuesday, after it announced disappointing top-line ...

Calluna Pharma, a biotech developing treatments for inflammatory and fibrotic diseases, has appointed Mark Gaffney as CEO.